Preexposure prophylaxis for the prevention of HIV infection in the United States  – 2017 update : a clinical practice guideline

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 update : a clinical practice guideline

Record #: 168 of 2139

Published Date:

March 2018

Status:

current

Language:

English

[PDF-1.67 MB]

Details:

Corporate Authors:

United States. Public Health Service. . Centers for Disease Control and Prevention (U.S.) . National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group.

Keywords:

[+]

Description:

The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2016: Update – A Clinical Practice Guideline includes revisions to several sections. These revisions are highlighted throughout the document and are intended solely to update the developing evidence base or to clarify specific points in clinical care. No changes were made to the graded recommendations for the use of PrEP in the US.

Suggested Citation: Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf. Published March 2018.

Document Type:

Book

Collection(s):

Guidelines and Recommendations

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline

Corporate Author:

United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).

Published:

05/07/2014

Description:

This publication provides a comprehensive clinical practice guideline for the use of PrEP for the prevention of HIV infection in the United States. It incorporates and extends information provided in interim guidance for PrEP use with MSM, with heter...

File Type:

[PDF - 791.62 KB]

You May Also Like:

Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 : clinical providers’ supplement

Corporate Author:

United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group..

Published:

March 2018

Description:

The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Providers’ Supplement was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence b...

Status:

current

File Type:

[PDF - 1.62 MB]
Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline

Corporate Author:

United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).

Published:

05/07/2014

Description:

This publication provides a comprehensive clinical practice guideline for the use of PrEP for the prevention of HIV infection in the United States. It incorporates and extends information provided in interim guidance for PrEP use with MSM, with heter...

File Type:

[PDF - 791.62 KB]
Characteristics of the provider-patient encounter associated with awareness of and willingness to take PrEP among young minority urban males in Baltimore City

Personal Author:

Chandran, Aruna; Marcell, Arik V.; Sanders, Renata Arrington; Perin, Jamie; Page, Kathleen R.; Loosier, Penny S.; Dittus, Patricia J.; Jennings, Jacky M.;

Published:

Jun 2019

Source:

AIDS Educ Prev. 31(3):237-245

Description:

We aimed to identify provider encounter characteristics associated with awareness of and willingness to take PrEP among young urban minority males at higher risk for HIV acquisition. The 74 individuals included in this analysis from a cross-sectional...

Public Access
Available on:

June 01, 2020
Preexposure prophylaxis for the prevention of HIV infection – 2014 : clinical providers’ supplement

Personal Author:

Smith, Dawn K.; Koenig, Linda J.; Martin, Michael; Mansergh, Gordon; Heneine, Walid; Ethridge, Steven F.; Morgan, Marie S.; Mermin, Jonathan; Fenton, Kevin A.;

Corporate Author:

United States. Public Health Service.. Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.).

Published:

May 14, 2014

Description:

For the Clinical Practice Guideline that serves as the basis for this Clinical Providers’ Supplement, see Preexposure prophylaxis for the prevention of HIV infection – 2014 : a clinical practice guideline....

Status:

superseded

File Type:

[PDF - 690.62 KB]

Update to Interim guidance for preexposure prophylaxis (PrEP) for the prevention of HIV infection : PrEP for injecting drug users

Personal Author:

Smith, Dawn K.; Martin, Michael; Lansky, Amy; Mermin, Jonathan; Choopanya, Kachit;

Corporate Author:

Centers for Disease Control and Prevention (U.S.). Bangkok Tenofovir Study Group..

Published:

June 14, 2013

Source:

MMWR. Morbidity and mortality weekly report. 2013 Jun 14; 62(23):463-5

Description:

On June 12, 2013, the Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of human immunodefic...

File Type:

[PDF - 72.62 KB]